UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017589 |
|---|---|
| Receipt number | R000020373 |
| Scientific Title | A phase II study of an oral nucleoside antitumor agent consisting trifluridine and tipiracil hydrochloride for previously fluoropyrimidine-treated elderly patients with unresectable or recurrent colorectal cancer (T-CORE1401) |
| Date of disclosure of the study information | 2015/05/15 |
| Last modified on | 2020/05/18 15:58:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/05/15 15:29:31 | ||
| 2 | Update | 2016/05/15 15:22:00 | Email Name of primary person or sponsor Organization |
|
| 3 | Update | 2017/04/10 20:39:06 | Last follow-up date |
|
| 4 | Update | 2017/05/23 20:12:41 | Recruitment status |
|
| 5 | Update | 2020/05/18 15:58:17 | Recruitment status Date of IRB Date analysis concluded |
